Provided by Tiger Fintech (Singapore) Pte. Ltd.

Elutia

2.30
-0.0200-0.86%
Post-market: 2.300.00000.00%16:00 EDT
Volume:12.96K
Turnover:29.56K
Market Cap:93.69M
PE:-1.24
High:2.33
Open:2.26
Low:2.19
Close:2.32
Loading ...

Company Profile

Company Name:
Elutia
Exchange:
NASDAQ
Establishment Date:
2015
Employees:
51
Office Location:
12510 Prosperity Drive,Suite 370,Silver Spring,Maryland,United States
Zip Code:
20904
Fax:
408 734 2629
Introduction:
Aziyo Biologics, Inc., a regenerative medicine company, focuses on the development of regenerative products to address the device protection, women's health, orthobiologics, cardiovascular, and soft tissue reconstruction markets. It offers CanGaroo that combines the envelope with antibiotics and is designed to reduce the risk of infection following surgical implantation of an electronic device. The company also provides cardiovascular products, such as ProxiCor for use as an intracardiac patch or pledget for tissue repairs; Tyke for use in neonates and infants to repair pericardial structures; and VasCure, a patch material to repair or reconstruct the peripheral vasculature, including the carotid, renal, iliac, femoral, and tibial blood vessels for cardiovascular, vascular, and general surgeons. In addition, it offers Fiber VBM, ViBone, and OsteGro V that are human tissue-derived bone allografts designed to protect and preserve native bone cells; and SimpliDerm, a pre-hydrated HADM designed to repair or replacement of damaged or inadequate integumental tissues. Further, the company provides contract manufacturing services for various products to corporate customers. It sells its products to hospitals and other healthcare facilities through its direct sales force, commercial partners, and independent sales agents. The company was incorporated in 2015 and is headquartered in Silver Spring, Maryland.

Directors

Name
Position
Kevin Rakin
Chairman
Ronald Lloyd
President, Chief Executive Officer and Director
Brigid A. Makes
Director
C. Randal Mills
Director
Maybelle Jordan
Director
W. Matthew Zuga
Director

Shareholders

Name
Position
Ronald Lloyd
President, Chief Executive Officer and Director
Matthew Ferguson
Chief Financial Officer
Darryl Roberts
Executive Vice President, Operations and Product Development
Jerome Riebman
Chief Medical Officer
Thomas Englese
Chief Commercial Officer